https://orcid.org/0000-0003-3437-0723
References
- Diagnosis of abnormal uterine bleeding in reproductive-aged women. ACOG Practice Bulletin No.128. July, 2012.
- Miller JD, Lenhart GM, Bonafede M, Basinski CM, Lukes AS, Troeger KA. Cost effectiveness of endometrial ablation with the NovaSure system vs other global ablation modalities and hysterectomy for treatment of abnormal bleeding: US commercial and medicaid payer perspectives. Int J Womens Health. 2015;7:59–73. doi:10.2147/IJWH.S75030
- Fergusson RJ, Lethaby A, Shepperde S, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding (review). Cochrane Database Syst Rev. 2013;11:CD000329.pub2.
- Mazzoni S, Brewer S, Durfee J, et al. Patient perspectives of obstetrician-gynecologists as primary care providers. J Reprod Med. 2017;62(1–2):3–8.
- Levie MD, Chudnoff SG. A prospective multicenter pivotal trial to evaluate the safety and effectiveness of the AEGEA vapor endometrial ablation system. J Minim Invasive Gynecol. 2019;26(4):679–687. doi:10.1016/j.jmig.2018.07.012
- Baker VL, Adamson GD. Threshold intrauterine perfusion pressures for intraperitoneal spill during hydrotubation and correlation with tubal adhesive disease. Fertil Steril. 1995;64(6):1066–1069. doi:10.1016/S0015-0282(16)57961-8
- Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97(8):734–739. doi:10.1111/j.1471-0528.1990.tb16249.x
- Bushnell DM, Martin ML, Moore KA, Richter HE, Rubin A, Patrick DL. Menorrhagia impact questionnaire: assessing the influence of heavy menstrual bleeding on quality of life. Curr Med Res Opin. 2010;26(12):2745–2755. doi:10.1185/03007995.2010.532200
- Soini T, Rantanen M, Paavonen J, et al. Long-term follow-up after endometrial ablation in Finland. Obstet Gynecol. 2017;130:554–560. doi:10.1097/AOG.0000000000002166
- Longinotti MK, Jacobson GF, Hung YY, Learman LA. Probability of hysterectomy after endometrial ablation. Obstet Gynecol. 2008;112(6):1214–1220. doi:10.1097/AOG.0b013e31818c1766
- Shavell VI, Diamond MP, Senter JP, Kruger ML, Johns DA. Hysterectomy subsequent to endometrial ablation. J Minim Invasive Gynecol. 2012;19(4):459–464. doi:10.1016/j.jmig.2012.03.013
- El Nashar E, Hopkins M, Creedon D, et al. Prediction of treatment outcomes after global endometrial ablation. Obstet Gynecol. 2009;113(1):97–106. doi:10.1097/AOG.0b013e31818f5a8d
- Dickersin K, Munro M, Clark M, et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding. Obstet Gynecol. 2007;110(6):1279–1289. doi:10.1097/01.AOG.0000292083.97478.38
- Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at 4 years. Br J Obstet Gynaecol. 1999;106:360–366. doi:10.1111/j.1471-0528.1999.tb08275.x
- Lybol C, van der Coelen S, Hamelink A, et al. Predictors of long-term novasure endometrial ablation failure. J Minim Invasive Gynecol. 2018;25(7):1255–1259. doi:10.1016/j.jmig.2018.03.006
- Novasure® Instructions for Use and Controller Operator's Manual. Marlborough, MA:Hologic Inc.
- Genesys HTATM System Instructions for Use. Marlborough MA:Boston Scientific.
- Minerva Endometrial Ablation System Instructions for Use. Redwood City, CA:Minerva Surgical.
- Her Option Office Cryoablation Therapy Instructions for Use. Trumbull CT:Cooper Surgical.
- Cerene® Cryotherapy Device Instructions for Use. Emeryville, CA:Channel Medsystems.
- Peeters J, Penninx J, Mol B, Bongers M. Prognostic factors for the success of endometrial ablation in the treatment of menorrhagia with special reference to cesarean section. Eur J Obstet Gynecol Reprod Biol. 2013;167:100–103. doi:10.1016/j.ejogrb.2012.11.009
- Aldape D, Chudnoff S, Levie M. Global endometrial ablation in the presence of essure® microinserts. Rev Obstet Gynecol. 2013;6(2):80–88.